AzTrials
AzTrials

GlaucomaNCT00328835

Optic Nerve Compliance Study

A study testing Brief Elevation of IOP in people with Glaucoma, run by Capital Vision Research Trust at 1 site in New Zealand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic glaucoma is one of the leading causes of blindness and visual loss in the developed world. It is a condition where long term exposure to high eye pressures (intra-ocular pressure) damages the nerve fibres in the eye. This damage can be seen by examiners as changes in the optic nerve. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Glaucoma
What is being tested?
Brief Elevation of IOP
Type of treatment
Surgery or procedure
How many people
100 participants
Where
1 siteNew Zealand
Study dates
Mar 2006to Apr 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Who may be able to join

  • Age over 18, Diagnosis of glaucoma (visual field proven), Stable, well controlled glaucoma

Who cannot join

  • Previous eye surgery, Best corrected visual acuity <6/9, Chronic eye disease (including glaucoma, Secondary glaucoma (eg uveitis, neovascular glaucoma, etc), Advanced or fixation-threatening visual field changes, Ocular perfusion abnormalities (e.g. previous retinal artery or vein occlusion; or abnormal vasculature including those whose retinal circulation might be compromised by pressure on the eye).

Trial locations and contacts

1 site in 1 country.

New Zealand1 site
  • Capital Vision Research Trust

    Wellington, 6001

Other trials in New Zealand

About this study

Chronic glaucoma is one of the leading causes of blindness and visual loss in the developed world. It is a condition where long term exposure to high eye pressures (intra-ocular pressure) damages the nerve fibres in the eye. This damage can be seen by examiners as changes in the optic nerve. The exact mechanism of how the high intra-ocular pressure causes nerve damage is unknown. Both physiological and mechanical mechanisms are thought to play a role. Previous authors have reported structural changes in the connective tissue of optic nerves of eyes with glaucoma. Structural changes in the optic nerve head which affect the mechanical compliance of the nerve may be significant in the cause of glaucomatous nerve damage. This study aims to assess the compliance of the optic disc in subjects with and without glaucoma. We would test compliance by imaging the optic discs of participants before and during a brief (less than two minutes) increase in intra-ocular pressure. We would aim to repeat the tests on the same subjects 3 years later to see how compliance changed. We would also seek to correlate other important parameters such as corneal thickness and visual field changes with our findings

Read the detailed description

Chronic glaucoma is one of the leading causes of blindness and visual loss in the developed world (the following reference gives rate of visual impairment/blindness caused by glaucoma in one cross-section of an older Australian population as 6% - Foran S, Wang JJ, Mitchell P. Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003 Oct;10(4):215-25). Glaucoma is a condition where long term exposure to high eye pressures (intra-ocular pressure) damages the nerve fibres in the eye. The exact mechanism of how the high intra-ocular pressure causes nerve damage is unknown (Albon J, Purslow PP, Karwatowski WS, Easty DL. Age related compliance of the lamina cribrosa in human eyes. Br J Ophthalmol. 2000 Mar;84(3):318-23). Both physiological and mechanical mechanisms are thought to play a role. Previous authors have reported structural changes in the connective tissue of optic discs of eyes with glaucoma, and postulated that this may contribute to changes in the compliance of the optic nerve head (Pena JD, Netland PA, Vidal I, Dorr DA, Rasky A, Hernandez MR. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy. Exp Eye Res. 1998 Nov;67(5):517-24). Structural changes in the optic nerve head which affect the mechanical compliance of the nerve may be significant in the cause of glaucomatous nerve damage. This study aims to assess the compliance of the optic disc in subjects with and without glaucoma. We would test compliance by imaging the optic discs of participants before and during a brief increase in intra-ocular pressure. We would aim to repeat the tests on the same subjects 3 years later to see how the optic nerve compliance changed. We would also look to correlate changes with other ocular parameters such as corneal thickness and visual field defects.

  1. Non-glaucoma group Inclusion criteria: Age over 18 Exclusion criteria: Previous eye surgery Best corrected visual acuity <6/9 Chronic eye disease (including glaucoma) Glaucomatous optic disc Ocular perfusion abnormalities (e.g. previous retinal artery or vein occlusion; or abnormal vasculature including those whose retinal circulation might be compromised by pressure on the eye).
  2. Glaucoma group

Inclusion criteria:

Age over 18 Diagnosis of glaucoma (visual field proven) Stable, well controlled glaucoma

Exclusion criteria:

Secondary glaucoma (eg uveitis, neovascular glaucoma, etc) Advanced or fixation-threatening visual field changes Previous eye surgery Chronic eye disease (not including glaucoma) Ocular perfusion abnormalities (e.g. previous retinal artery or vein occlusion; or abnormal vasculature including those whose retinal circulation might be compromised by pressure on the eye).

Two different groups of participants will be studied, those with glaucoma, and those without glaucoma. Participants will have a routine eye examination performed by an experienced doctor. Information such as visual acuity, intra-ocular pressure, corneal thickness, and optic nerve appearance will be obtained. Then participants will have their optic nerves imaged by a Heidelberg retinal tomograph (HRT). The intra-ocular pressure will then be artificially raised to approximately 50 mmHg for approximately two to four minutes using a suction cup oculopressor. The optic nerve will be imaged again by the HRT during that time. From the HRT images we will calculate the optic nerve compliance using measures such as mean position of the disc, and optic cup area and volume. This data will then be analysed statistically to look for a significant difference in the optic nerve compliance of the two groups. Participants will then undergo the same testing procedure 3 years later to see how their optic nerve compliance has changed. We will then examine these changes to see how they correlate with changes in their vision. These changes would include: development of glaucoma; decreased visual acuity; reduced visual field.

Clinical methods - history and examination. Visual field testing (in those with glaucoma) using an automated visual field testing machine.

Intra-ocular pressure measurement using a Goldmann tonometer. Corneal thickness measurement using a "Pachmate", pachymeter. Optic disc images using a Heidelberg retinal tomograph (a confocal scanning diode laser ophthalmoscope).

There is a theoretical risk that a short term rise in intra-ocular can compromise the blood supply to the optic nerve and cause optic nerve damage. However a previous study looking at optic nerve compliance found no side-effects after a short term rise in intraocular pressure induced with a suction cup (Augusto, A., Harris, A., Cantor, L., Abreu, M., \& Weinland, M. Effects of short term increase of intraocular pressure on optic disc cupping. British Journal of Ophthalmology. 1998. 82, 880-883). Also a recent study has shown that a short term rise in intra-ocular pressure does not alter the response of retinal and optic nerve head blood flow (Garhofer, G., Resch, H., Weigert., Lung, S., Simader, C. \& Schmetterer, L. Short-term increase of intraocular pressure does not alter the response of retinal and optic nerve head blood flow to flicker stimulation. Investigative Ophthalmology \& Visual Science. 2005. 46(5), 880-883). We also know from clinical experience that patients with short term rises in intra-ocular pressure caused by vitreo-retinal surgery and acute angle closure glaucoma do not have long term side effects from raised pressure for hours.

To further reduce the risk of side-effects we will exclude those with advanced or fixation threatening glaucoma changes. We will also exclude those whose retinal circulation is seen to be compromised by digital pressure on the eye during examination.

Conditions
Glaucoma
Being tested
Brief Elevation of IOP
Keywords
Optic Nerve, Glaucoma
Medical subject headings
Glaucoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief Elevation of IOPProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Optic Disc Change

  2. Visual Field Progression

Secondary outcomes (1)
  1. Visual Acuity Change

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2006 (estimated)
  2. Study startMar 2006
  3. Study completionApr 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00328835
Sponsor's protocol ID
ONCS
Status last verified
May 2006
First submitted
18 May 2006
Last updated
17 Oct 2006
Results posted
No

Publications

  • Poostchi A, Wong T, Chan KC, Kedzlie L, Sachdev N, Nicholas S, Garway-Heath DF, Wells AP. Optic disc diameter increases during acute elevations of intraocular pressure. Invest Ophthalmol Vis Sci. 2010 May;51(5):2313-6. doi: 10.1167/iovs.09-3756. Epub 2009 Nov 11.

    PubMed 19907027
  • Wells AP, Garway-Heath DF, Poostchi A, Wong T, Chan KC, Sachdev N. Corneal hysteresis but not corneal thickness correlates with optic nerve surface compliance in glaucoma patients. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3262-8. doi: 10.1167/iovs.07-1556. Epub 2008 Mar 3.

    PubMed 18316697

Questions about this trial

What is this clinical trial studying?

A study testing Brief Elevation of IOP in people with Glaucoma, run by Capital Vision Research Trust at 1 site in New Zealand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Oct 2006. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in New Zealand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Optic Disc Change. The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00328835, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2006; AzTrials last refreshed its copy on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in